All Episodes
The Cancer Letter — 13 episodes
Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement
The Directors: Two Midwest directors tell us about the challenging healthcare economics in rural areas
Policy by way of podcaster—FDA issues priority vouchers after Joe Rogan episode on psychedelics
Peter F. Garrett to people with cancer: Your story has power
Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
The Directors: NCORP PIs discuss the growing complexity of regulatory oversight in clinical cancer research
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue
Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time
On the joys of reporting on art as a tool for cancer education
The Directors: NCORP PIs discuss the growing complexity of regulatory oversight in clinical cancer research